# The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms

> **NCT02294279** · PHASE4 · COMPLETED · sponsor: **Research in Real-Life Ltd** · enrollment: 360 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** Qvar (100 mcg)

## Key facts

- **NCT ID:** NCT02294279
- **Lead sponsor:** Research in Real-Life Ltd
- **Sponsor class:** NETWORK
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2016-08
- **Final completion:** 2016-08
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2017-04-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02294279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02294279, "The Evaluation of FeNO for Predicting Response to ICS in Subjects With Non-specific Respiratory Symptoms". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT02294279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*